ALPS Advisors’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-987
| Closed | -$175K | – | 1036 |
|
2023
Q1 | $175K | Sell |
987
-26
| -3% | -$4.6K | ﹤0.01% | 988 |
|
2022
Q4 | $391K | Buy |
+1,013
| New | +$391K | ﹤0.01% | 685 |
|
2019
Q4 | – | Sell |
-2,579
| Closed | -$1.7M | – | 866 |
|
2019
Q3 | $1.7M | Buy |
2,579
+268
| +12% | +$176K | 0.01% | 230 |
|
2019
Q2 | $1.79M | Sell |
2,311
-336
| -13% | -$260K | 0.01% | 239 |
|
2019
Q1 | $1.87M | Buy |
2,647
+115
| +5% | +$81.2K | 0.01% | 230 |
|
2018
Q4 | $1.19M | Buy |
+2,532
| New | +$1.19M | 0.01% | 273 |
|
2016
Q2 | – | Sell |
-851
| Closed | -$190K | – | 638 |
|
2016
Q1 | $190K | Sell |
851
-145
| -15% | -$32.4K | ﹤0.01% | 606 |
|
2015
Q4 | $605K | Sell |
996
-160
| -14% | -$97.2K | 0.01% | 269 |
|
2015
Q3 | $5.95K | Buy |
1,156
+528
| +84% | +$2.72K | 0.01% | 241 |
|
2015
Q2 | $275K | Buy |
628
+314
| +100% | +$138K | ﹤0.01% | 661 |
|
2015
Q1 | $114K | Buy |
+314
| New | +$114K | ﹤0.01% | 653 |
|